Enterobiotix

Scottish biopharmaceutical firm EnteroBiotix has raised over £27 million from new and existing investors, positioning it to expand and accelerate its pioneering work in developing microbiome medicines. The £27m financing includes new equity of £6m from the Scottish National Investm